Enteral Vancomycin to Eliminate MRSA Carriership of the Digestive Tract in Critically Ill Patients

Enteral Vancomycin to Eliminate MRSA Carriership of the Digestive Tract in Critically Ill Patients

Background: Carriership with methicillin resistant <i>Staphylococcus aureus</i> (MRSA) is a risk for the development of secondary infections in critically ill patients. Previous studies suggest that enteral vancomycin is able to eliminate enteral carriership with MRSA. Data on individual...

Full description

Bibliographic Details
Main Authors: Sophie H. Buitinck, Matty Koopmans, Rogier M. Determann, Rogier R. Jansen, Peter H. J. van der Voort
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Antibiotics
Subjects:
vancomycin
oral
MRSA
carriership
colonization
SDD
Online Access:https://www.mdpi.com/2079-6382/11/2/263

Internet

https://www.mdpi.com/2079-6382/11/2/263

Similar Items